Patent · US Active

Inhibitors of APOL1 and methods of using same

US12116343B2 · kind B2 · utility

0Cited by

5References

33Claims

0Family size

Assignee

Vertex Pharmaceuticals Incorporated · US

Inventors

Leslie Dakin · Waltham, US
Timothy J. Senter · Arlington, US
Jingrong Cao · Newton, US
Jon Come · Cambridge, US
Francois Denis · Saint Lazare, CA
Warren Dorsch · Boston, US
Anne Fortier · Rockville, US
Martine Hamel · Boston, US
Elaine B. Krueger · Cambridge, US
Brian Ledford · Attleboro, US
Francois Maltais · Somerville, US
Suganthini S. Nanthakumar · Newton, US
Olivier Nicolas · Winston-Salem, US
Camil SAYEGH · Belmont, US
Tiansheng Wang · Concord, US
Stéphane Dorich · Rue du Bois des Loges, CA
Lee Fader · Laval, CA
Claudio Sturino · Montréal, CA
Janek Szychowski · Shannon, CA

Key dates

Filing date	Jan 28, 2021
Grant date	Oct 15, 2024
Priority date	—
Expiry date	Jan 28, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D491/107
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure provides at least one entity chosen from compounds of Formula (I)

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.